Transparency Market Research Report Added "Antivirals Market" to its database.
Albany, NY -- (SBWIRE) -- 03/29/2016 -- Transparency Market Research presents a 360-degree view of the global antivirals market through its new research report. The research report, titled "Antivirals Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019," details the overall antivirals market with the help of Porter's five forces analysis to bring out the bargaining power of suppliers, the threat of new entrants, the threat of substitute products or services, the bargaining power of customers, and the intensity of competitive rivalry. Furthermore, the research report has also used SWOT analysis to highlight the strengths, weaknesses, opportunities, and threats influencing the segments of the overall antivirals market. The research report has been compiled using primary and secondary research methodologies to present a utilizable databank to the readers for making profitable business decisions.
The global antivirals market is being driven by the increasing research and development activities, rising expenditure on healthcare, growing awareness of diseases amongst the overall population, and high incidence of life-threatening diseases. The WHO states that there were 35.3 million people across the globe with HIV in October 2013, a number that is only expected to rise in the coming years. Increasing research and development has led to advanced treatments with powerful formulations such as combination therapies and a new range of vaccines being introduced in the antivirals market. The only factors restraining the growth of this market are the capital-intensive nature of research and development, the risk of failure, and the lack of support from governments.
The global antivirals market is segmented on the basis of product type into HIV antivirals, hepatitis-C antivirals, hepatitis-B antivirals, herpes antivirals, influenza antivirals, and others. On the basis of enzymes, this market is segmented into NS3 protease inhibitors, DNA polymerase inhibitors, reverse transcriptase inhibitors, and others. Geographically, this market is segmented into Asia Pacific, Europe, North America, and Rest of the World. The biggest market for antiviral drugs is the U.S., which is closely followed by Japan and U.K. According to analysts, the Africa and Asia Pacific regional markets will give an incredible impetus to the global antivirals market in the coming few years.
Brochure Download: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2306
Some of the key players in the global antivirals market are GlaxoSmithKline, plc. AstraZeneca AB, Abbott Laboratories, Novartis International AG, Boehringer Ingelheim Corporation, Johnson & Johnson, and Merck and Co. Inc. The research report profiles these players and gives a detailed analysis of the competitive landscape of the global antivirals market. It provides an insightful take on the financial overview, business and marketing strategies, branding and expansions plans, investment outlook, and research and development activities of these top players in the global antivirals market.
Mr. Sudip S
Transparency Market Research
90 State Street,
NY - 12207
USA - Canada Toll Free 866-552-3453